CagriSema combines two molecules that both slow gastric emptying. Semaglutide 2.4 mg is the GLP-1 component, cagrilintide 2.4 mg is the long-acting amylin analogue, and the combined effect on stomach motility is the source of most clinically relevant drug interactions. When the stomach empties slower, oral drugs absorb slower, and the absorption curve gets flatter and later.<\/p>\n
Most of what we know comes from semaglutide trials (SUSTAIN, STEP, SELECT) and cagrilintide phase 2 data, plus the REDEFINE 1 phase 3 results released in March 2025. The combined product hasn’\\”t generated unique interaction data yet, but the additive effect on gastric emptying is the clinical mental model to use.<\/p>\n
At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.<\/p>\n
The mechanism is delayed gastric emptying, full stop.<\/strong> Semaglutide slows it by roughly 30 to 70% depending on dose and time since injection, with the strongest effect in the first 24 hours after a dose. Cagrilintide has a similar effect through amylin receptors in the area postrema. Stacked together, food and pills sit in the stomach longer.<\/p>\n Quick Answer: Oral contraceptive absorption is not clinically reduced by semaglutide in pharmacokinetic studies, but vomiting within 1 hour of the pill counts as a missed dose<\/p>\n That changes Tmax (time to peak concentration) for many oral drugs, sometimes by 1 to 3 hours. Total exposure (AUC) is usually preserved, meaning the drug eventually reaches the same blood level. The clinical concern is acute drugs where peak matters: short-acting opioids, immediate-release stimulants, and anything where a missed peak feels like a missed dose.<\/p>\n Steady-state oral drugs you take daily for chronic conditions (statins, ACE inhibitors, SSRIs, levothyroxine, oral contraceptives) generally do fine after the first week of adjustment. The body equilibrates because AUC is what drives the steady-state level.<\/p>\n Yes, with one caveat.<\/strong> Semaglutide pharmacokinetic studies showed no clinically meaningful reduction in ethinyl estradiol or levonorgestrel exposure when taken alongside semaglutide. The Wegovy\u00ae label specifically allows continued use of combined oral contraceptives without backup contraception.<\/p>\n The caveat is vomiting. If you vomit within 1 to 2 hours of taking your pill, treat it as a missed dose per the standard manufacturer guidance. CagriSema patients in the REDEFINE 1 trial had a vomiting rate around 16 to 19% during titration, peaking in weeks 4 to 12. If you’\\”re experiencing real GI side effects in the first 12 weeks, an IUD, implant, or backup barrier method is the conservative move.<\/p>\n Pregnancy must be avoided entirely on CagriSema. The Wegovy label requires discontinuation 2 months before any planned pregnancy because of the 1-week half-life. Cagrilintide has a similar half-life. Patients planning pregnancy should stop CagriSema and switch to an alternative weight management plan well in advance.<\/p>\n Anyone on insulin or a sulfonylurea (glipizide, glyburide, glimepiride) needs proactive dose reduction when starting CagriSema.<\/strong> Hypoglycemia is the predictable risk because GLP-1 + amylin lower glucose independently, and combining them with insulin or insulin secretagogues stacks the effect.<\/p>\n Starting protocol from the SUSTAIN program and applied to combination products: reduce basal insulin by 20% at the time of the first CagriSema injection, and reduce mealtime insulin by 30 to 50% based on carb intake and recent glucose patterns. Check fasting and post-meal glucose 2 to 4 times daily for the first 2 weeks.<\/p>\n Sulfonylureas should be cut by 50% on day one or stopped entirely if A1c was already under 7.0%. Many endocrinologists drop them at GLP-1 initiation because the hypoglycemia risk outweighs the small additional A1c reduction.<\/p>\n Warfarin needs closer INR monitoring for 2 to 4 weeks after starting CagriSema.<\/strong> The interaction isn’\\”t through CYP metabolism (warfarin uses CYP2C9 and CYP3A4, semaglutide doesn’\\”t touch them), but absorption timing shifts. Some patients see INR drift up or down by 0.5 to 1.0 in the first month. Check INR weekly until stable, then return to your usual interval.<\/p>\n Direct oral anticoagulants (DOACs) like apixaban, rivaroxaban, and dabigatran don’\\”t require monitoring, but the same absorption-shift principle applies. If you’\\”re bridging through a procedure, account for the possibility that peak DOAC level lands later than usual. Clinical bleeding events haven’\\”t been reported as a class signal.<\/p>\n Aspirin and clopidogrel are unaffected.<\/p>\n Yes, but timing matters more than usual.<\/strong> Levothyroxine absorption is already finicky and depends on an acidic, empty stomach. Slowed gastric emptying could reduce absorption if the pill stays in the stomach long enough to encounter food residue, calcium, iron, or PPIs.<\/p>\n Take levothyroxine at least 30 to 60 minutes before any food, supplements, or other oral medications, including coffee. This guidance doesn’\\”t change on CagriSema. Recheck TSH 6 to 8 weeks after starting because dose adjustments are sometimes needed, particularly if you’\\”ve also lost significant weight (which can change thyroid requirements independently).<\/p>\n Iron, calcium, and aluminum-containing antacids should be separated from levothyroxine by 4 hours regardless.<\/p>\n Acetaminophen is fine.<\/strong> Pharmacokinetic studies with semaglutide showed Tmax delayed by about 1 hour but total exposure unchanged. NSAIDs (ibuprofen, naproxen) are also fine pharmacokinetically but bring their own GI concerns. CagriSema already causes nausea and reflux in many patients, and stacking an NSAID worsens that.<\/p>\n Opioids are the harder question. Short-acting oxycodone, hydrocodone, and tramadol can have delayed onset because of slowed gastric emptying, leading some patients to double-dose thinking the first pill didn’\\”t work. Then both pills hit at once 2 hours later. If you’\\”re on chronic opioid therapy, switching to extended-release formulations or transdermal fentanyl avoids this entirely.<\/p>\n Opioids also slow gastric emptying themselves, so the additive effect with CagriSema can produce severe gastroparesis-like symptoms.<\/p>\n SSRIs, SNRIs, bupropion, and tricyclics are pharmacokinetically fine.<\/strong> The clinical issue is additive GI side effects. Sertraline and fluoxetine commonly cause nausea on their own, especially early in treatment. Starting CagriSema during the first month of an SSRI compounds this. Most prescribers will stabilize one drug first.<\/p>\n ADHD stimulants (methylphenidate, amphetamine salts) are usually fine but watch for delayed peak. Immediate-release formulations may feel weaker because the absorption curve flattens. Extended-release formulations (Adderall XR, Concerta, Vyvanse\u00ae) are more forgiving.<\/p>\n MAO inhibitors haven’\\”t shown specific interaction signals.<\/p>\n Key Takeaway: Levothyroxine should be taken 30 to 60 minutes before food and any oral drugs, including any other supplements<\/p>\n Statins are unaffected at steady state.<\/strong> Rosuvastatin Tmax shifted slightly in semaglutide PK studies, but AUC was preserved. No dose change needed.<\/p>\n ACE inhibitors, ARBs, calcium channel blockers, and beta-blockers don’\\”t share metabolism pathways with semaglutide or cagrilintide and don’\\”t show clinically meaningful interactions. The exception is real blood pressure drops as you lose weight. Many patients on CagriSema need their antihypertensive dose reduced after 3 to 6 months because blood pressure falls 5 to 8 mmHg on average. Check BP at home weekly and report sustained readings under 110\/70.<\/p>\n Diuretics deserve special caution because GLP-1-induced nausea and vomiting can produce dehydration. Loop diuretics combined with CagriSema and inadequate fluid intake have triggered acute kidney injury in case reports.<\/p>\n Pharmacokinetically, no.<\/strong> Semaglutide and cagrilintide aren’\\”t metabolized through pathways alcohol affects. The practical concerns are different.<\/p>\n First, alcohol on a delayed-emptying stomach can produce unpredictable absorption. The same two glasses of wine can hit harder one night and barely register the next, depending on how recently you injected and what you ate.<\/p>\n Second, alcohol calories are appetite-blind. CagriSema works partly by suppressing hunger, and you can drink yourself out of your calorie deficit without ever feeling full.<\/p>\n Third, alcohol plus insulin or sulfonylureas plus CagriSema is a hypoglycemia setup, especially overnight. If you have diabetes, glucose monitoring after evening drinking is essential.<\/p>\n Many TrimRx patients on personalized treatment plans report that their alcohol tolerance and desire both drop noticeably on GLP-1s, which the literature confirms in alcohol use disorder studies of semaglutide.<\/p>\n Anticonvulsants like lamotrigine, levetiracetam, valproate, and topiramate don’\\”t share metabolism with semaglutide or cagrilintide.<\/strong> The class is generally safe to continue on CagriSema. Topiramate is interesting because it’\\”s already FDA-approved as an obesity drug (Qsymia includes topiramate plus phentermine). Combining topiramate with CagriSema is not formally studied, and stacking two appetite-suppressing mechanisms can cause dehydration and cognitive side effects.<\/p>\n Phenytoin and carbamazepine are CYP450 inducers, but since neither semaglutide nor cagrilintide is metabolized through CYP enzymes, no clinically significant interaction is expected. Drug-level monitoring proceeds as usual.<\/p>\n Immunosuppressants used in transplant or autoimmune disease deserve closer attention. Tacrolimus, cyclosporine, mycophenolate, and sirolimus all have narrow therapeutic windows and depend on consistent absorption. CagriSema’\\”s delayed gastric emptying can shift the absorption profile. Most transplant teams want a 2 to 4 week period of more frequent trough level checks when starting a GLP-1, with dose adjustments as needed.<\/p>\n Most common supplements are fine.<\/strong> Multivitamins, vitamin D, omega-3s, magnesium, B vitamins, and probiotics don’\\”t interact with CagriSema pharmacokinetically. Some patients on GLP-1s use magnesium glycinate or citrate to help with the constipation that affects roughly 1 in 5 users.<\/p>\n Berberine has gained popularity as a glucose-lowering supplement. Combining berberine with CagriSema in a diabetic patient could compound hypoglycemia risk, particularly with concurrent metformin or insulin. The data on berberine is thinner than the marketing suggests, and stacking it with prescription glucose-lowering drugs without monitoring is risky.<\/p>\n Senna, bisacodyl, and other stimulant laxatives are commonly used short-term for CagriSema-induced constipation. They’\\”re safe for occasional use. Chronic daily use of stimulant laxatives causes dependency and electrolyte issues. Bulk-forming fiber and osmotic agents like polyethylene glycol are safer long-term.<\/p>\n St. John’\\”s Wort is the herbal interaction most clinicians worry about for other drugs, but since semaglutide and cagrilintide aren’\\”t CYP-metabolized, it doesn’\\”t directly affect them. It can interfere with other medications you’\\”re on, so the same caution applies as before.<\/p>\n Any new medication started after CagriSema deserves a quick check, even OTC products.<\/strong> The fastest screen is: “Does the package insert or pharmacy printout mention slowed gastric emptying or delayed absorption as a concern?” If yes, ask before starting. If no, it’\\”s probably fine.<\/p>\n Symptoms that warrant a call: sudden severe abdominal pain (pancreatitis check), repeated hypoglycemia in a diabetic patient (means insulin or sulfonylurea dose is too high), unexplained bleeding or bruising (warfarin INR check), and new symptoms after starting any new medication within the past 2 weeks.<\/p>\n For TrimRx patients on personalized treatment plans, the clinical team reviews drug interactions at every check-in and adjusts dosing or timing as needed. The free assessment quiz captures your current medication list up front so the prescribing clinician can flag interactions before starting.<\/p>\n Bottom line: Alcohol doesn’\\”t interact pharmacokinetically but compounds nausea and hypoglycemia risk in diabetics<\/p>\n Yes. Caffeine has no pharmacokinetic interaction. Many patients report increased coffee sensitivity because slower gastric emptying delays the absorption peak. Reducing your daily intake by 20 to 30% during the first month is common.<\/p>\n No formal drug interaction studies, but cannabinoids and GLP-1s both affect appetite and gastric motility. THC can blunt CagriSema’\\”s appetite suppression. CBD is unlikely to interact. Heavy daily cannabis users sometimes lose less weight than expected on GLP-1s, but evidence is mostly observational.<\/p>\n Generally yes. Creatine and protein powders are commonly used on GLP-1s to preserve lean mass. Magnesium can help with constipation, which affects roughly 20% of GLP-1 patients. Bulk-forming fiber (psyllium) is fine and often helpful. Keep iron and calcium separated from levothyroxine by 4 hours.<\/p>\n Probably yes, with timing depending on procedure. The American Society of Anesthesiologists 2023 guidance suggests holding GLP-1s for 1 to 2 weeks before elective procedures requiring general anesthesia because of aspiration risk from delayed gastric emptying. CagriSema adds amylin on top, so most anesthesiologists will want at least 2 weeks off.<\/p>\n You can’\\”t stack them. CagriSema already contains semaglutide 2.4 mg at the full weight-management dose. Adding more semaglutide would just amplify side effects without proportional benefit. Switching from semaglutide monotherapy to CagriSema means stopping one and starting the other at the appropriate titration step.<\/p>\n Metformin is unaffected. DPP-4 inhibitors (sitagliptin, linagliptin) overlap mechanistically with GLP-1s, and continuing them on top of CagriSema offers minimal added benefit. Most prescribers stop DPP-4s. SGLT2 inhibitors are independent and often continued, with added cardiovascular and renal benefits.<\/p>\n Yes, non-oral contraceptives bypass the absorption issue entirely. Implants, IUDs, the patch, and the ring are unaffected by CagriSema. Many clinicians recommend switching to a non-oral method during the first 4 to 6 months because of the vomiting risk.<\/p>\n Disclaimer:<\/strong> This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.<\/p>\n <\/p>\n CagriSema combines two molecules that both slow gastric emptying.<\/p>\n","protected":false},"author":11,"featured_media":92631,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_yoast_wpseo_title":"CagriSema Drug Interactions: What You Can and Can'\\''t Take with It","_yoast_wpseo_metadesc":"CagriSema combines two molecules that both slow gastric emptying.","_yoast_wpseo_focuskw":"cagrisema drug interactions","footnotes":"","_flyrank_wpseo_metadesc":""},"categories":[6],"tags":[20],"class_list":["post-89205","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-glp-1","tag-cagrisema"],"_links":{"self":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/89205","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/comments?post=89205"}],"version-history":[{"count":4,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/89205\/revisions"}],"predecessor-version":[{"id":93632,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/89205\/revisions\/93632"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media\/92631"}],"wp:attachment":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media?parent=89205"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/categories?post=89205"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/tags?post=89205"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Do Oral Contraceptives Still Work on CagriSema?<\/h2>\n
How Do You Adjust Insulin and Sulfonylureas?<\/h2>\n
What About Warfarin and Other Anticoagulants?<\/h2>\n
Can You Still Take Levothyroxine for Hypothyroidism?<\/h2>\n
What Pain Meds Are Safe?<\/h2>\n
Are There Interactions with Antidepressants and Stimulants?<\/h2>\n
Do Statins and Blood Pressure Meds Need Adjustment?<\/h2>\n
Alcohol on CagriSema: Is It Actually Dangerous?<\/h2>\n
How Does CagriSema Interact with Anticonvulsants and Immunosuppressants?<\/h2>\n
What About Herbal Supplements and Over-the-counter Products?<\/h2>\n
When Should You Contact Your Prescriber About a Possible Interaction?<\/h2>\n
FAQ<\/h2>\n
Can I Drink Coffee on CagriSema?<\/h3>\n
What About Cannabis or CBD?<\/h3>\n
Can I Take Supplements Like Creatine, Magnesium, or Fiber?<\/h3>\n
Should I Stop CagriSema Before Surgery?<\/h3>\n
What If I’\\”m on Ozempic\u00ae-style Compounded Semaglutide Already?<\/h3>\n
Does CagriSema Affect Oral Diabetes Pills Besides Sulfonylureas?<\/h3>\n
Will My Birth Control Implant or IUD Still Work?<\/h3>\n
Related Articles<\/h2>\n
\n